Announcements Trials
Browse Landscape

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Plasma cell 1

Conditions

Small Cell Lung Carcinoma 1Prolactinoma 1Pituitary ACTH Hypersecretion 1Paraproteinemias 1Multiple Myeloma 1Monoclonal Gammopathy of Undetermined Significance 1Mesothelioma, Malignant 1Immunoglobulin Light-chain Amyloidosis 1Head and Neck Neoplasms 1Gigantism 1Congenital Abnormalities 1Combined Pituitary Hormone Deficiency 1Carcinogenesis 1Acromegaly 1

Interventions

Dexamethasone 2Cyclophosphamide 2Clinical Protocols 2Bortezomib 2daratumumab 1Tissue Banks 1Rifaximin 1Clonal Hematopoiesis 1Chromatin Immunoprecipitation Sequencing 1CLR1404 1Blood Cell Count 14-(N-methylamino)-4'-(2-(2-(2-fluoroethoxy)ethoxy)ethoxy)stilbene 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Paraproteinemias × Tissue Banks × 90 days × Clear all
NCT01408225 2026-03-23

B-SCR-MM

Ohio State University Comprehensive Cancer Center

Recruiting
5,000 enrolled
Plasma cell

Immunoglobulin Light-chain Amyloidosis, Monoclonal Gammopathy of Undetermined Significance, Multiple Myeloma, Paraproteinemias

Data powered by HemOnc (CC BY 4.0) Colophon âš¡